Literature DB >> 33480599

The 2020 WHO Classification of Tumors of Bone: An Updated Review.

Joon Hyuk Choi1, Jae Y Ro2.   

Abstract

Bone tumors are a rare and heterogeneous group of neoplasms that occur in the bone. The diversity and considerable morphologic overlap of bone tumors with other mesenchymal and nonmesenchymal bone lesions can complicate diagnosis. Accurate histologic diagnosis is crucial for appropriate management and prognostication. Since the publication of the fourth edition of the World Health Organization (WHO) classification of tumors of soft tissue and bone in 2013, significant advances have been made in our understanding of bone tumor molecular biology, classification, prognostication, and treatment. Detection of tumor-specific molecular alterations can facilitate the accurate diagnosis of histologically challenging cases. The fifth edition of the 2020 WHO classification of tumors of soft tissue and bone tumors provides an updated classification scheme and essential diagnostic criteria for bone tumors. Herein, we summarize these updates, focusing on major changes in each category of bone tumor, the newly described tumor entities and subtypes of existing tumor types, and newly described molecular and genetic data.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33480599     DOI: 10.1097/PAP.0000000000000293

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  22 in total

1.  Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone.

Authors:  Ioannis Panagopoulos; Kristin Andersen; Ludmila Gorunova; Marius Lund-Iversen; Ingvild Lobmaier; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

Review 2.  The 2020 World Health Organization classification of bone tumors: what radiologists should know.

Authors:  Sinchun Hwang; Meera Hameed; Mark Kransdorf
Journal:  Skeletal Radiol       Date:  2022-07-19       Impact factor: 2.128

3.  Up-regulation of matrix metalloproteinase-9 in primary bone tumors and its association with tumor aggressiveness.

Authors:  Mohammad Amin Vaezi; Amir Reza Eghtedari; Banafsheh Safizadeh; Ghasem Ghasempour; Vahid Salimi; Mitra Nourbakhsh; Shima Nazem; Masoumeh Tavakoli-Yaraki
Journal:  Mol Biol Rep       Date:  2022-08-24       Impact factor: 2.742

4.  Primary High-Grade Myxoid Liposarcoma of the Extremities: Prognostic Factors and Metastatic Pattern.

Authors:  Gianmarco Tuzzato; Roberta Laranga; Federico Ostetto; Elisa Bubbico; Giulio Vara; Giuseppe Bianchi
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

Review 5.  Surgical Treatment of Bone Sarcoma.

Authors:  Felix Bläsius; Heide Delbrück; Frank Hildebrand; Ulf Krister Hofmann
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

6.  Prediction of the early recurrence in spinal giant cell tumor of bone using radiomics of preoperative CT: Long-term outcome of 62 consecutive patients.

Authors:  Qizheng Wang; Yang Zhang; Enlong Zhang; Xiaoying Xing; Yongye Chen; Min-Ying Su; Ning Lang
Journal:  J Bone Oncol       Date:  2021-03-16       Impact factor: 4.072

7.  Primary Bone Lymphoma: A Rare Cause of Chronic Back Pain.

Authors:  Guilherme Cunha; Martim Alçada; Ana Mestre; Marta B Duarte; Filomena Roque
Journal:  Cureus       Date:  2022-01-12

8.  Giant Cell Tumors of Bone in Patients Aged 18 Years Old or Younger: Imaging Features and Tumor Characteristics.

Authors:  Xue-Ping Zhang; Xin-Chang Lu; Lin-Lin Wang; Jie-Qin Wei; Jing Yan; Xiao-Ning Shao; Ying-Yu Che; Jing-Liang Cheng
Journal:  Int J Gen Med       Date:  2021-11-18

Review 9.  Update on the imaging features of the enchondromatosis syndromes.

Authors:  Ban Sharif; Daniel Lindsay; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-07-24       Impact factor: 2.199

Review 10.  Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies.

Authors:  Richa Rathore; Brian A Van Tine
Journal:  J Clin Med       Date:  2021-03-12       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.